VOYA Investment Management
XERS icon

VOYA Investment Management’s Xeris Biopharma Holdings XERS Stock Holding History

VOYA Investment Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.43M Buy
685,570
+60,260
+10% +$385K ﹤0.01% 836
2026
Q1 		$3.63M Buy
625,310
+166,981
+36% +$1.11M ﹤0.01% 960
2025
Q4 		$3.6M Buy
458,329
+58,250
+15% +$458K ﹤0.01% 995
2025
Q3 		$3.26M Buy
400,079
+358,689
+867% +$2.38M ﹤0.01% 1042
2025
Q2 		$193K Buy
41,390
+1,595
+4% +$7.31K ﹤0.01% 2338
2025
Q1 		$218K Sell
39,795
-4,958
-11% -$20K ﹤0.01% 2264
2024
Q4 		$152K Sell
44,753
-3,613
-7% -$11.6K ﹤0.01% 2473
2024
Q3 		$138K Sell
48,366
-366
-0.8% -$940 ﹤0.01% 2586
2024
Q2 		$110K Buy
48,732
+4,633
+11% +$9.34K ﹤0.01% 2640
2024
Q1 		$97.5K Sell
44,099
-11,778
-21% -$30.5K ﹤0.01% 2624
2023
Q4 		$131K Buy
55,877
+2,031
+4% +$3.75K ﹤0.01% 2691
2023
Q3 		$100K Hold
53,846
– – ﹤0.01% 2732
2023
Q2 		$141K Buy
53,846
+2,415
+5% +$6.15K ﹤0.01% 2698
2023
Q1 		$83.8K Hold
51,431
– – ﹤0.01% 2727
2022
Q4 		$68.4K Hold
51,431
– – ﹤0.01% 2815
2022
Q3 		$80.2K Hold
51,431
– – ﹤0.01% 2830
2022
Q2 		$79K Buy
+51,431
New +$109K ﹤0.01% 2678
2021
Q2 		– Sell
-20,975
Closed -$95K – 2910
2021
Q1 		$95K Hold
20,975
– – ﹤0.01% 2678
2020
Q4 		$103K Buy
20,975
+5,996
+40% +$30K ﹤0.01% 2555
2020
Q3 		$89K Buy
14,979
+1,776
+13% +$7.1K ﹤0.01% 2363
2020
Q2 		$35K Sell
13,203
-193
-1% -$672 ﹤0.01% 2480
2020
Q1 		$26K Hold
13,396
– – ﹤0.01% 2570
2019
Q4 		$94K Buy
13,396
+3,382
+34% +$27.9K ﹤0.01% 2562
2019
Q3 		$98K Hold
10,014
– – ﹤0.01% 2419
2019
Q2 		$115K Buy
+10,014
New +$105K ﹤0.01% 2434

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

VOYA Investment Management's XERS Position: Q2 2026 in Review

VOYA Investment Management increased its Xeris Biopharma Holdings (XERS) stake by 9.6% in Q2 2026, buying an estimated $385K and bringing the position to 685,570 shares worth $5.43M. The position accounts for ﹤0.01% of the portfolio, ranked #836.

VOYA Investment Management first reported a position in XERS in Q2 2019 and has held it in 25 quarters since. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • VOYA Investment Management held 685,570 shares of Xeris Biopharma Holdings worth $5.43M as of Q2 2026.
  • VOYA Investment Management bought 60,260 Xeris Biopharma Holdings shares in Q2 2026, an estimated $385K.
  • Xeris Biopharma Holdings made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #836 holding.
  • VOYA Investment Management first reported a position in Xeris Biopharma Holdings in Q2 2019 and has held it in 25 quarters since.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.